Ronald Newbold

Ronald Newbold

Director/Board Member at
The University of Virginia Patent Foundation
63 year
Health Technology
Consumer Services
Commercial Services

Profile

Ronald C.
Newbold
is currently the Vice Chairman at The University of Virginia Patent Foundation.
Previously, he held senior positions at Merck & Co., Inc., Sentigen Holding Corp., AVANT Immunotherapeutics, Inc., Celldex Therapeutics, Inc. (Old), Auspex Pharmaceuticals, Inc., and Sentigen Biosciences, Inc. He also served as the Vice President of Business Development at Celldex Therapeutics, Inc. Dr. Newbold holds a doctorate from the University of Rochester and an MBA from The Trustees of Columbia University in The City of New York.

Ronald Newbold active positions

CompaniesPositionStart
Director/Board Member -

Former positions of Ronald Newbold

CompaniesPositionEnd
Chief Operating Officer 27/04/2011
CELLDEX THERAPEUTICS, INC. Corporate Officer/Principal 30/01/2009
Corporate Officer/Principal 01/10/2008
Sentigen Biosciences, Inc.
Corporate Officer/Principal 01/01/2004
MERCK & CO., INC. Corporate Officer/Principal 01/01/2000
See the detail of Ronald Newbold's experience

Training of Ronald Newbold

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

85

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Consumer Services

Health Technology

Sentigen Biosciences, Inc.

Health Technology

Commercial Services

  1. Stock Market
  2. Insiders
  3. Ronald Newbold
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!